Abstract Objective To evaluate the effect of hypothermia therapy on serum glial fibrillary acidic protein (GFAP) and ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) levels in neonates with hypoxic-ischemic encephalopathy (HIE). Methods Sixty-four HIE neonates were enrolled in this study. Thirty-three neonates with mild HIE were given conventional treatment and 31 neonates with moderate or severe HIE received conventional treatment and hypothermia therapy. Serum levels of GFAP and UCH-L1 were measured using ELISA before treatment and 6-12 hours after treatment. Results Serum levels of IL-6, IL-8, GFAP and UCH-L1 in the moderate/severe HIE group were significantly higher than in the mild HIE group (P<0.05) before treatment. Serum GFAP level was positively correlated with serum IL-6 (r=0.54; P<0.05) and IL-8 levels (r=0.63; P<0.05) , while negatively correlated with Apgar score (r=-0.47, P<0.05). After treatment, serum levels of IL-6, IL-8 and UCH-L1 in the moderate/severe HIE group were significantly reduced (P<0.05), while serum GFAP levels increased significantly (P<0.05). The patients with abnormal neurological development showed higher serum GFAP levels than those with favourable prognosis (P<0.05). Receiver operating characteristic (ROC) curves analysis demonstrated that the area under curve (AUC) of GFAP and UCH-L1 were 0.714 and 0.703 respectively. At a cut-off value of 0.07 ng/mL, the sensitivity and specificity of GFAP for the diagnosis of HIE were 77% and 78% respectively. Conclusions Hypothermia therapy can decrease serum UCH-L1 levels and increase serum GFAP levels in neonates with HIE. Based on their diagnostic value of brain injury, GFAP and UCH-L1 are promising to be novel biomarkers for HIE.
JIANG Shu-Hong,WANG Jin-Xiu,ZHANG Yi-Ming et al. Effect of hypothermia therapy on serum GFAP and UCH-L1 levels in neonates with hypoxic-ischemic encephalopathy[J]. CJCP, 2014, 16(12): 1193-1196.
JIANG Shu-Hong,WANG Jin-Xiu,ZHANG Yi-Ming et al. Effect of hypothermia therapy on serum GFAP and UCH-L1 levels in neonates with hypoxic-ischemic encephalopathy[J]. CJCP, 2014, 16(12): 1193-1196.
Douglas-Escobar M, Weiss MD. Biomarkers of brain injury in The premaTure infanT[J]. FronT Neurol, 2012, 3(1): 185-192.
[3]
Middeldorp J, Hol EM. GFAP in healTh and disease[J]. Prog Neurobiol, 2011, 93(3): 421-443.
[4]
Papa L, Akinyi L, Liu MC, eT al. UbiquiTin C-Terminal hydrolase is a novel biomarker in humans for severe TraumaTic brain injury[J]. CriT Care Med, 2010, 38(1): 138-144.
Papa L, Lewis LM, Falk JL, eT a1. ElevaTed levels of serum glialfibfilary acidic proTein breakdown producTs in mild and moderaTe TraumaTic brain injury are associaTed wiTh inTracranial lesions and neurosurgical inTervenTion[J]. Ann Emerg Med, 2012, 59(6): 471-783.
[8]
Silver J, Miller JH. RegeneraTion beyond The glial scar[J]. NaT Rev Neurosci, 2004, 5(2): 146-156.
[9]
Liu NK, Zhang YP, TiTsworTh WL, eT a1. A nove1 role of phospholipase A2 in mediaTing spinal cord secondary injury[J]. Ann Neurol, 2006, 59(4): 606-619.
[10]
FosTer-Barber A, Dickens B, Ferriero DM. Human perinaTal asphyxia: correlaTion of neonaTal cyTokines wiTh MRI and ouTcome[J]. Dev Neurosci, 2001, 23(3): 213-218.
[11]
Brophy GM, Mondello S, Papa L, eT a1. BiokineTic analysis of ubiquiTin C-Terminal hydrolase-L1(UCH-L1) in severe TraumaTic brain injury paTienT biofluids[J]. J NeuroTrauma, 2011, 28(6): 86l-870.
[12]
Mondello S, LinneT A, Buki A, eT a1. Clinical uTiliTy of serum levels of ubiquiTin C-Terminal hydrolase as a biomarker for severe TraumaTic brain injury[J]. Neurosurgery, 2012, 70(3): 666-675.
[13]
Chalak LF, Sanchez PJ, Adams-HueT B, eT al. Biomarkers for severiTy of neonaTal hypoxic-ischemic encephalopaThy and ouTcomes in newborns receiving hypoThermia Therapy[J]. J PediaTr, 2014, 164(3): 468-474.
